Occudo Quantitative Strategies LP Raises Stake in CorVel Co. (NASDAQ:CRVL)

Occudo Quantitative Strategies LP grew its stake in shares of CorVel Co. (NASDAQ:CRVL) by 184.3% in the fourth quarter, Holdings Channel reports. The firm owned 4,467 shares of the business services provider’s stock after acquiring an additional 2,896 shares during the period. Occudo Quantitative Strategies LP’s holdings in CorVel were worth $497,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. LGT Financial Advisors LLC lifted its stake in CorVel by 200.0% in the fourth quarter. LGT Financial Advisors LLC now owns 255 shares of the business services provider’s stock worth $28,000 after acquiring an additional 170 shares during the period. Bessemer Group Inc. lifted its stake in CorVel by 6,350.0% in the fourth quarter. Bessemer Group Inc. now owns 258 shares of the business services provider’s stock worth $29,000 after acquiring an additional 254 shares during the period. Fifth Third Bancorp lifted its stake in CorVel by 45.9% in the fourth quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock worth $36,000 after acquiring an additional 101 shares during the period. Jones Financial Companies Lllp purchased a new stake in CorVel in the fourth quarter worth about $37,000. Finally, US Bancorp DE lifted its stake in CorVel by 225.4% in the fourth quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock worth $43,000 after acquiring an additional 266 shares during the period. 51.36% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Jeffrey J. Michael sold 16,523 shares of the company’s stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $116.99, for a total transaction of $1,933,025.77. Following the transaction, the director now owns 551,787 shares in the company, valued at $64,553,561.13. This represents a 2.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Alan Hoops sold 10,200 shares of the company’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the transaction, the director now owns 118,213 shares in the company, valued at approximately $13,758,811.07. This trade represents a 7.94% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 37,200 shares of company stock worth $4,340,250. 47.57% of the stock is owned by corporate insiders.

CorVel Stock Performance

Shares of CorVel stock opened at $110.03 on Friday. The company has a market capitalization of $5.65 billion, a PE ratio of 64.72 and a beta of 1.10. The company has a 50-day simple moving average of $111.05 and a two-hundred day simple moving average of $116.27. CorVel Co. has a one year low of $76.53 and a one year high of $128.61.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of CorVel from a “hold” rating to a “buy” rating in a research note on Friday, April 18th.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.